FDA Inspection 1203954 - Thymoorgan Pharmazie Gmbh - April 25, 2023

Record Details

This FDA Inspection record concerns Thymoorgan Pharmazie Gmbh, with an inspection on April 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Thymoorgan Pharmazie Gmbh
Inspection Date: April 25, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 9ff3fdca-2e03-4d87-ab7e-b6d311bbaf32

Violation Codes3

21 CFR 211.100(b)21 CFR 211.19221 CFR 211.42(c)(10)(iv)

Full citation text and observation details available on the Dashboard.